155 related articles for article (PubMed ID: 16222866)
1. Rheology of nanostructured lipid carriers (NLC) suspended in a viscoelastic medium.
Souto EB; Gohla SH; Müller RH
Pharmazie; 2005 Sep; 60(9):671-3. PubMed ID: 16222866
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations.
Souto EB; Wissing SA; Barbosa CM; Müller RH
J Cosmet Sci; 2004; 55(5):463-71. PubMed ID: 15608996
[TBL] [Abstract][Full Text] [Related]
3. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
Silva AC; Santos D; Ferreira DC; Souto EB
Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
6. Development of lycopene-loaded nanostructured lipid carriers: effect of rice oil and cholesterol.
Riangjanapatee P; Müller RH; Keck CM; Okonogi S
Pharmazie; 2013 Sep; 68(9):723-31. PubMed ID: 24147340
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Teeranachaideekul V; Müller RH; Junyaprasert VB
Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
[TBL] [Abstract][Full Text] [Related]
8. Physical and chemical stability of nanostructured lipid drug carriers (NLC) based on natural lipids from Baikal region (Siberia, Russia).
Averina ES; Müller RH; Popov DV; Radnaeva LD
Pharmazie; 2011 May; 66(5):348-56. PubMed ID: 21699068
[TBL] [Abstract][Full Text] [Related]
9. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents.
Souto EB; Müller RH
Pharmazie; 2006 May; 61(5):431-7. PubMed ID: 16724541
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
11. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
12. Beta-carotene-loaded nanostructured lipid carriers.
Hentschel A; Gramdorf S; Müller RH; Kurz T
J Food Sci; 2008 Mar; 73(2):N1-6. PubMed ID: 18298743
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
[TBL] [Abstract][Full Text] [Related]
14. The effect of oil type on the aggregation stability of nanostructured lipid carriers.
Yang Y; Corona A; Schubert B; Reeder R; Henson MA
J Colloid Interface Sci; 2014 Mar; 418():261-72. PubMed ID: 24461844
[TBL] [Abstract][Full Text] [Related]
15. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
[TBL] [Abstract][Full Text] [Related]
16. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
[TBL] [Abstract][Full Text] [Related]
17. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]